IL214809A0 - Biomarkers for the prediction of renal injury - Google Patents

Biomarkers for the prediction of renal injury

Info

Publication number
IL214809A0
IL214809A0 IL214809A IL21480911A IL214809A0 IL 214809 A0 IL214809 A0 IL 214809A0 IL 214809 A IL214809 A IL 214809A IL 21480911 A IL21480911 A IL 21480911A IL 214809 A0 IL214809 A0 IL 214809A0
Authority
IL
Israel
Prior art keywords
biomarkers
prediction
renal injury
renal
injury
Prior art date
Application number
IL214809A
Original Assignee
Compugen Ltd
Shira Wallach
Amit Novik
Shirly Sameah Greenwald
Anat Cohen Dayag
Gad S Cojocaru
Beiman Merav
Yaron Kinar
Tania Pergam
Yael Furman
Montia Eve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compugen Ltd, Shira Wallach, Amit Novik, Shirly Sameah Greenwald, Anat Cohen Dayag, Gad S Cojocaru, Beiman Merav, Yaron Kinar, Tania Pergam, Yael Furman, Montia Eve filed Critical Compugen Ltd
Priority to IL214809A priority Critical patent/IL214809A0/en
Publication of IL214809A0 publication Critical patent/IL214809A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/142Toxicological screening, e.g. expression profiles which identify toxicity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL214809A 2009-03-01 2011-08-23 Biomarkers for the prediction of renal injury IL214809A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL214809A IL214809A0 (en) 2009-03-01 2011-08-23 Biomarkers for the prediction of renal injury

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IL2009/000235 WO2010100633A1 (en) 2009-03-01 2009-03-01 Biomarkers for the prediction of renal injury
IL214809A IL214809A0 (en) 2009-03-01 2011-08-23 Biomarkers for the prediction of renal injury

Publications (1)

Publication Number Publication Date
IL214809A0 true IL214809A0 (en) 2011-11-30

Family

ID=41278600

Family Applications (1)

Application Number Title Priority Date Filing Date
IL214809A IL214809A0 (en) 2009-03-01 2011-08-23 Biomarkers for the prediction of renal injury

Country Status (3)

Country Link
EP (1) EP2403958A1 (en)
IL (1) IL214809A0 (en)
WO (1) WO2010100633A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102539745B (en) * 2010-12-31 2013-03-06 中国人民解放军第三〇九医院 Early diagnosis and early warning kit for transplanted kidney rejection reaction and detection method
CN103592444A (en) * 2013-11-27 2014-02-19 中国人民解放军沈阳军区总医院 Method for detecting cyclin G1 protein expression in breast cancer and carrying out prognosis evaluation
JP6232689B2 (en) 2015-06-25 2017-11-22 株式会社国際電気通信基礎技術研究所 Prediction device and prediction program based on multi-organ linkage system
CN114778845A (en) 2016-03-29 2022-07-22 无限生物制药公司 Pharmaceutical or food composition and method for evaluating in vivo effect of active ingredient
EP3438282A4 (en) * 2016-03-29 2020-05-06 Advanced Telecommunications Research Institute International Screening method for candidate substances for active component to prevent or treat at least one disease selected from the group consisting of renal hypofunction, chronic kidney disease and kidney failure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7588892B2 (en) * 2004-07-19 2009-09-15 Entelos, Inc. Reagent sets and gene signatures for renal tubule injury
WO2009083950A2 (en) * 2007-12-27 2009-07-09 Compugen Ltd. Biomarkers for the prediction of renal injury

Also Published As

Publication number Publication date
WO2010100633A1 (en) 2010-09-10
EP2403958A1 (en) 2012-01-11

Similar Documents

Publication Publication Date Title
EP2619577A4 (en) Biomarkers of renal injury
IL206631A0 (en) Biomarkers for the prediction of renal injury
HUE064692T2 (en) Inter prediction
PT2559240T (en) Inter-plane prediction
IL222232A0 (en) Circulating biomarkers for disease
IL216720A (en) Biomarkers for assessing kidney diseases
IL215753A0 (en) Merging search results
EP2606353A4 (en) Circulating biomarkers for disease
HK1153538A1 (en) Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events -1
GB2474618B (en) Predictive biomarkers
ZA201703026B (en) Biomarkers for the prediction of incident cancer
GB201008340D0 (en) Biomarkers
GB201018056D0 (en) Biomarkers
GB0921329D0 (en) Biomarker
GB0903417D0 (en) Biomarkers
IL214809A0 (en) Biomarkers for the prediction of renal injury
GB201005561D0 (en) Biomarkers
GB201001444D0 (en) Biomarkers
GB0915736D0 (en) Biomarkers
EP2554994A4 (en) Biomarkers
GB201005456D0 (en) Biomarkers
IL217333A0 (en) Biomarker
GB201010316D0 (en) Biomarkers
GB0903391D0 (en) Biomarkers
GB0912175D0 (en) Biomarker